mRNA-Based Genetic Reprogramming.

The discovery that ordinary skin cells can be turned into pluripotent stem cells by the forced expression of defined factors has raised hopes that personalized regenerative treatments based on immunologically compatible material derived from a patient's own cells might be realized in the not-too-distant future. A major barrier to the clinical use of induced pluripotent stem cells (iPSCs) was initially presented by the need to employ integrating viral vectors to express the factors that induce an embryonic gene expression profile, which entails potentially oncogenic alteration of the normal genome. Several "non-integrating" reprogramming systems have been developed over the last decade to address this problem. Among these techniques, mRNA reprogramming is the most unambiguously "footprint-free," most productive, and perhaps the best suited to clinical production of stem cells. Herein, we discuss the origins of the mRNA-based reprogramming system, its benefits and drawbacks, recent technical improvements that simplify its application, and the status of current efforts to industrialize this approach to mass-produce human stem cells for the clinic.

[1]  K. Jensen,et al.  In vitro and ex vivo strategies for intracellular delivery , 2016, Nature.

[2]  M. Hasegawa,et al.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[3]  Xi-rong Guo,et al.  Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA , 2012, Scientific Reports.

[4]  J. Cooke,et al.  Optimal ROS Signaling Is Critical for Nuclear Reprogramming. , 2016, Cell reports.

[5]  J. Kříž,et al.  Synthetic mRNA is a more reliable tool for the delivery of DNA-targeting proteins into the cell nucleus than fusion with a protein transduction domain , 2017, PloS one.

[6]  P. Andrews,et al.  Activation of Pluripotency Genes in Human Fibroblast Cells by a Novel mRNA Based Approach , 2010, PloS one.

[7]  Johanna E. Goldmann,et al.  Efficient Reprogramming of Human Fibroblasts and Blood-Derived Endothelial Progenitor Cells Using Nonmodified RNA for Reprogramming and Immune Evasion. , 2015, Human gene therapy.

[8]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[9]  D. Melton,et al.  Synthesis of long, capped transcripts in vitro by SP6 and T7 RNA polymerases. , 1989, Methods in enzymology.

[10]  E. Dolgin.  Business: The billion-dollar biotech , 2015, Nature.

[11]  Dong Wook Han,et al.  Generation of induced pluripotent stem cells using recombinant proteins. , 2009, Cell stem cell.

[12]  Saiyong Zhu,et al.  Reprogramming cell fates by small molecules , 2017, Protein & Cell.

[13]  Anders Lindahl,et al.  Footprint‐Free Human Induced Pluripotent Stem Cells From Articular Cartilage With Redifferentiation Capacity: A First Step Toward a Clinical‐Grade Cell Source , 2014, Stem cells translational medicine.

[14]  L. Milanesi,et al.  RNA‐Generated and Gene‐Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy , 2017, Journal of cellular physiology.

[15]  D. Normile.  First-of-its-kind clinical trial will use reprogrammed adult stem cells to treat Parkinson’s , 2018, Science.

[16]  M. Yanik,et al.  Innate Immune Suppression Enables Frequent Transfection with RNA Encoding Reprogramming Proteins , 2010, PloS one.

[17]  Michel Sadelain,et al.  Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation , 2009, Proceedings of the National Academy of Sciences.

[18]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[19]  A. Muotri,et al.  Efficient generation of human iPSCs by a synthetic self-replicative RNA. , 2013, Cell stem cell.

[20]  D. Givol,et al.  Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. , 2010, Biochemical and biophysical research communications.

[21]  A. Hoffman,et al.  Rapid and Efficient Conversion of Integration-Free Human Induced Pluripotent Stem Cells to GMP-Grade Culture Conditions , 2014, PloS one.

[22]  B. Sullenger,et al.  Differential effects of toll-like receptor stimulation on mRNA-driven myogenic conversion of human and mouse fibroblasts. , 2016, Biochemical and biophysical research communications.

[23]  Houping Ni,et al.  Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. , 2005, Immunity.

[24]  M. Fussenegger,et al.  mRNA transfection-based, feeder-free, induced pluripotent stem cells derived from adipose tissue of a 50-year-old patient. , 2013, Metabolic engineering.

[25]  J. Gurdon,et al.  The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. , 1962, Journal of embryology and experimental morphology.

[26]  S. Yamanaka.  Induced pluripotent stem cells: past, present, and future. , 2012, Cell stem cell.

[27]  D. Weissman,et al.  Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development. , 2007, Current opinion in drug discovery & development.

[28]  Derrick J. Rossi,et al.  Reprogramming human fibroblasts to pluripotency using modified mRNA , 2013, Nature Protocols.

[29]  D. Weissman,et al.  Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA , 2011, Nucleic acids research.

[30]  C. van Broeckhoven,et al.  Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. , 2001, Blood.

[31]  Alexander Meissner,et al.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.

[32]  Xin Li,et al.  A comparison of non-integrating reprogramming methods , 2014, Nature Biotechnology.

[33]  H. Würtele,et al.  Illegitimate DNA integration in mammalian cells , 2003, Gene Therapy.

[34]  Robert Lanza,et al.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.

[35]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[36]  T. Enver,et al.  Forcing cells to change lineages , 2009, Nature.

[37]  Shinya Yamanaka,et al.  Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors , 2008, Science.

[38]  N. Elango,et al.  Optimized transfection of mRNA transcribed from a d(A/T)100 tail-containing vector. , 2005, Biochemical and biophysical research communications.

[39]  U. Şahin,et al.  Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. , 2006, Blood.

[40]  J. Melki,et al.  Messenger RNA‐ Versus Retrovirus‐Based Induced Pluripotent Stem Cell Reprogramming Strategies: Analysis of Genomic Integrity , 2014, Stem cells translational medicine.

[41]  Jiwu Wang,et al.  Feeder-free reprogramming of human fibroblasts with messenger RNA. , 2013, Current protocols in stem cell biology.

[42]  J. Adjaye,et al.  Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc. , 2012, Biomaterials.

[43]  W. Wong,et al.  Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming , 2012, Cell.

[44]  A. Alcamí,et al.  Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity , 1995, Cell.

[45]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[46]  Alexander Meissner,et al.  Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells , 2015, Nature Methods.

[47]  Jiwu Wang,et al.  cGMP Generation of Human Induced Pluripotent Stem Cells with Messenger RNA. , 2016, Current protocols in stem cell biology.

[48]  Kristopher L. Nazor,et al.  Whole-genome mutational burden analysis of three pluripotency induction methods , 2016, Nature Communications.

[49]  Lei Zhang,et al.  Pluripotent State Induction in Mouse Embryonic Fibroblast Using mRNAs of Reprogramming Factors , 2014, International journal of molecular sciences.

[50]  S. Weissman,et al.  Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytes. , 2008, Human gene therapy.

[51]  Shizuo Akira,et al.  Antiviral signaling through pattern recognition receptors. , 2006, Journal of biochemistry.

[52]  J. Utikal,et al.  Induced Pluripotent Stem Cells Generated Without Viral Integration , 2008, Science.

[53]  K. Mitani,et al.  Adenovirus as an integrating vector. , 2002, Current gene therapy.

[54]  W. Wong,et al.  Early role for IL-6 signalling during generation of induced pluripotent stem cells revealed by heterokaryon RNA-Seq , 2013, Nature Cell Biology.

[55]  C. Chariau,et al.  Urine-derived cells provide a readily accessible cell type for feeder-free mRNA reprogramming , 2018, Scientific Reports.

[56]  Hiroki Kato,et al.  Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[57]  T. Ichisaka,et al.  Hypoxia enhances the generation of induced pluripotent stem cells. , 2009, Cell stem cell.